Stock Value LensCharts for long-term investors100% free

Stock Value Lens vs. Finviz

US market screening, heatmaps and technical charts. This comparison uses published product and plan information checked October 20, 2026. See provider sources for current details.

Short answer

Choose Stock Value Lens for: free historical U.S. charts, annual SEC filing-based facts, and transparent historical calculations.

Choose Finviz for: US market screening, heatmaps and technical charts. Main tradeoff: Fast US-market screening, heatmaps and technical analysis. It is US-focused; real-time quotes, exports and expanded tools require Elite.

Free versions: side by side

Free access and core research workflow
AreaStock Value LensFinviz
Stock coverage6,551 US-listed securities in the Oct 9, 2026 snapshot; 4,209 have published chart pages with usable prices and at least two annual per-share observations.US-stock screener; exact number of Free-available listings not stated.
Price historyWeekly prices through Oct 8, 2026; among 6,550 securities with price observations, history spans a median ~7.5 years and up to 25 years. 2,817 have at least 10 years and 1,727 at least 20 years.Free charts; uniform historical lookback not stated.
Financial-statement historyAnnual SEC Company Facts through Oct 9, 2026; 4,655 securities have annual facts, with a median ~13-year span and up to 21 years. 2,736 have at least 10 years.Company fundamentals and ratios; long annual statement history is not a free-plan focus.
Data sources and metricsSEC Company Facts and linked filings; Stooq adjusted closes or checked split-only closes where available. EPS, FCF/share, revenue/share, debt/share, P/E, P/S, P/FCF, margins, dividends/yield, FCF/net income and ROCE.Finviz covers U.S.-listed Nasdaq, NYSE and AMEX stocks. Its screener groups fields into valuation (P/E, PEG, P/S, P/B, P/FCF), growth, dividends, profitability/margins, liquidity/leverage, ownership/insider activity, performance and technical indicators. Fundamentals update hourly; the reviewed pages do not name one upstream provider.
Company comparisonFree head-to-head chart for 2–3 companies, up to 10 of 20 metric variants, one shared date range, and no account required.Screener/heatmaps rather than a historical company-to-company fundamentals chart.
Free accessAll site features are free; no account or subscription.Free stock screener and charts with limits/ads; real-time data and expanded screener tools are paid.

Paid tiers: prices and published benefits

Finviz paid tiers and features as publicly listed
Tier and pricePublished inclusions and limits
Paid plansFree; Elite $39.50/mo or $299.50/yr.Elite adds real-time quotes and charts, advanced screening, export/API access, alerts and an ad-free interface.

Prices are provider-listed USD prices where visible, checked October 20, 2026. Billing term, region, taxes and checkout options can change the amount.

Product depth and tradeoffs

Coverage: US stocks and ETFs are the main focus; no equivalent global coverage count was stated in reviewed product pages. Price history: Charting is available; a standardized historical lookback was not specified on the reviewed pricing page. Financial history: Fundamental metrics and company data, but not a long-form financial-statement-history product comparable to annual history tools.

Sources: Finviz documents its U.S. exchange universe and screener field definitions, and says fundamentals are recalculated hourly using recent information releases. Its public FAQ does not identify a single underlying fundamentals vendor. Metrics: Fundamental and technical screener filters, valuation ratios, insider activity, news and heatmaps. Comparison tools: Screener and heatmap exploration; not a dedicated historical fundamentals comparison workspace.

Questions about Stock Value Lens vs. Finviz

Which tool is a better fit for my workflow?

Choose Stock Value Lens for free U.S. historical charts with filing-linked annual facts and transparent calculations. Choose Finviz if you need us market screening, heatmaps and technical charts. Its main tradeoff: Fast US-market screening, heatmaps and technical analysis. It is US-focused; real-time quotes, exports and expanded tools require Elite.

What is free, and what requires a paid plan?

Stock Value Lens is free with no account or subscription. Finviz free access: Free stock screener and charts with limits/ads; real-time data and expanded screener tools are paid. Paid tiers: Free; Elite $39.50/mo or $299.50/yr. Elite adds real-time quotes and charts, advanced screening, export/API access, alerts and an ad-free interface.

How do stock coverage and history compare?

Stock Value Lens: 6,551 US-listed securities in the Oct 9, 2026 snapshot; 4,209 have published chart pages with usable prices and at least two annual per-share observations. Weekly prices through Oct 8, 2026; among 6,550 securities with price observations, history spans a median ~7.5 years and up to 25 years. 2,817 have at least 10 years and 1,727 at least 20 years. Annual SEC Company Facts through Oct 9, 2026; 4,655 securities have annual facts, with a median ~13-year span and up to 21 years. 2,736 have at least 10 years. Finviz: US-stock screener; exact number of Free-available listings not stated. Free price history: Free charts; uniform historical lookback not stated. Free financial history: Company fundamentals and ratios; long annual statement history is not a free-plan focus. Paid history and broader coverage: US stocks and ETFs are the main focus; no equivalent global coverage count was stated in reviewed product pages. Charting is available; a standardized historical lookback was not specified on the reviewed pricing page. Fundamental metrics and company data, but not a long-form financial-statement-history product comparable to annual history tools.

Which metrics and research features differ?

Stock Value Lens: EPS, FCF/share, revenue/share, debt/share, P/E, P/S, P/FCF, margins, dividends/yield, FCF/net income and ROCE. Its free head-to-head chart compares 2–3 companies and up to 10 of 20 metric variants. Finviz: Finviz covers U.S.-listed Nasdaq, NYSE and AMEX stocks. Its screener groups fields into valuation (P/E, PEG, P/S, P/B, P/FCF), growth, dividends, profitability/margins, liquidity/leverage, ownership/insider activity, performance and technical indicators. Fundamentals update hourly; the reviewed pages do not name one upstream provider. Comparison tools: Screener and heatmap exploration; not a dedicated historical fundamentals comparison workspace.

Where does the data come from, and how current is it?

Stock Value Lens uses SEC Company Facts and linked filings; Stooq adjusted closes or checked split-only closes where available. Current snapshot: weekly price data through Oct 8, 2026, and SEC Company Facts through Oct 9, 2026; prices and filing data refresh on separate schedules. Finviz: Finviz documents its U.S. exchange universe and screener field definitions, and says fundamentals are recalculated hourly using recent information releases. Its public FAQ does not identify a single underlying fundamentals vendor. Update timing: Finviz says fundamentals are recalculated hourly; regular US stock quotes are delayed one minute, while Elite quotes are real-time. Check the linked provider documentation below for current coverage and methodology.

Visit Finviz for current plan details.

Sources and methodology links

Last checked October 20, 2026. Stock Value Lens data snapshot dates: weekly prices through Oct 8, 2026; SEC facts through Oct 9, 2026. All comparisons · Stock Value Lens methodology.